Orthotopic liver transplantation (OLT), which replaces the source of mutant TTR, has been mainly used in patients with early-stage polyneuropathy without cardiac involvement [14]; however, this strategy has been utilized much less in recent years after the introduction of medical therapy [14]. The gene discussed is TTR; the disease is polyneuropathy.